secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENERON PHARMACEUTICALS, INC. (REGN)
CIK:        0000872589
Form:       8-K
Filed at:   2021-09-16T23:59:59+00:00
Accession:  0001104659-21-116352
Event type: other_material
Sentiment:  positive
Materiality: 0.90
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Regeneron to supply 1.4M additional REGEN-COV doses to U.S. Government for $2.94B
--------------------------------------------------------------------------------

- Amendment obligates U.S. Government to buy 1.4 million doses at $2,100 each, totaling $2.94 billion.
- Regeneron must deliver at least 100,000 doses per month (Sept–Dec 2021); all by January 31, 2022.
- Doses are for use under FDA Emergency Use Authorization for certain individuals in the U.S.
- Agreement includes government's right to terminate for convenience; Regeneron gets termination costs based on work performed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/872589/000110465921116352/0001104659-21-116352-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/872589/000110465921116352/tm2127757d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-116352

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer